BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8971086)

  • 41. Does insulin release kinins in rats?
    Damas J; Garbacki N; Lefèbvre PJ
    Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition.
    Ferri C; Laurenti O; Bellini C; Faldetta MR; Properzi G; Santucci A; De Mattia G
    Am J Hypertens; 1995 Jan; 8(1):40-7. PubMed ID: 7734095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells.
    Gräfe M; Bossaller C; Graf K; Auch-Schwelk W; Baumgarten CR; Hildebrandt A; Fleck E
    Am J Physiol; 1993 May; 264(5 Pt 2):H1493-7. PubMed ID: 8388656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel mechanism for vascular insulin resistance in normotensive young SHRs: hypoadiponectinemia and resultant APPL1 downregulation.
    Xing W; Yan W; Liu P; Ji L; Li Y; Sun L; Tao L; Zhang H; Gao F
    Hypertension; 2013 May; 61(5):1028-35. PubMed ID: 23478100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.
    Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
    Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein.
    Nowak W; Goldschmidt ED; Falcioni AG; Pugliese MI; Errasti AE; Pelorosso FG; Daray FM; Gago JE; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):221-9. PubMed ID: 17372720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium.
    Formoso G; Chen H; Kim JA; Montagnani M; Consoli A; Quon MJ
    Mol Endocrinol; 2006 May; 20(5):1153-63. PubMed ID: 16373398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
    Félétou M; Germain M; Teisseire B
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H839-45. PubMed ID: 1558194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of angiotensin-converting enzyme in human hand veins.
    Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats.
    Jaffa AA; Pratt J; Ashford A; Bailey GS
    Adv Exp Med Biol; 1986; 198 Pt B():373-8. PubMed ID: 3028079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.
    Seth MK; Hussain ME; Pasha S; Fahim M
    Drug Des Devel Ther; 2016; 10():1533-42. PubMed ID: 27143859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of captopril, losartan, and bradykinin on early steps of insulin action.
    Carvalho CR; Thirone AC; Gontijo JA; Velloso LA; Saad MJ
    Diabetes; 1997 Dec; 46(12):1950-7. PubMed ID: 9392479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
    Hecker M; Benzing T; Busse R
    Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of endothelin receptors in the hypertensive state of kinin B(2) knockout mice subjected to a high-salt diet.
    Brochu I; Labonté J; Bkaily G; D'Orléans-Juste P
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():380S-384S. PubMed ID: 12193127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.
    Liu YH; You Y; Song T; Wu SJ; Liu LY
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):155-61. PubMed ID: 17703131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
    Anning PB; Grocott-Mason RM; Lewis MJ
    Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.